Ultra-rapid lispro or fast-acting aspart compared to standard insulin lispro and aspart using closed-loop insulin therapy: a systematic review and meta-analysis of randomized control trials

BackgroundUltra-rapid-acting insulin (URAI) improves glycemic control by reducing variability; however, optimal strategies for its use, especially within hybrid closed-loop (HCL) insulin delivery systems, remain unclear. This meta-analysis assesses the efficacy and safety of combining URAI with HCL...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mohamed Saad Rakab, Rahma Mogahed Rateb, Basel Hatem Elsalakawi, Bashar M. Al Zoubi, Abubakar Nazir, Mutaz Moath Abu-Laila, Abdelrahman Sherif Ghanem, Alaa Maamoun, Mohab Mattar, Basma Ataallah, Brian T. Layden, Abeer M. Mahmoud
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-06-01
Serija:	Frontiers in Endocrinology
Teme:	closed-loop systems ultra fast acting insulin analogs type 1 diabetes glucose variability meta-analysis
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1600157/full
Oznake:	Označite Brez oznak, prvi označite!